The 45-minute webinar will be essential viewing for everyone interested in learning why RNA-Seq delivers novel biological discoveries and how best to design an NGS gene expression study that delivers true biological insight. As part of the webinar, Dr Swan will utilise OGT’s NGS data reporting interface, which makes it quick, easy and intuitive to visualise gene and transcript expression levels, identify isoforms and perform SNP and indel analysis for a range of eukaryotes.
To register for the webinar please visit the sign-up page (http://view6.workcast.net/
For more information about OGT’s RNA-Seq, targeted sequencing (http://www.ogt.co.uk/
For further information, please contact:
Oxford Gene Technology, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, Oxfordshire, OX5 1PF, U.K.
T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684 ; E: email@example.com
W: www.ogt.co.uk ; Twitter: @OxfordGeneTech (https://twitter.com/#!/
About Oxford Gene Technology
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine. www.ogt.co.uk.
Diagnostic Biomarkers: Utilising proprietary next generation technologies, OGT is building a rich patent-protected portfolio of promising biomarkers for early-stage cancer and autoimmune disease detection. The biomarker pipeline includes advanced programmes in colorectal cancer, prostate cancer and pancreatic cancer plus the autoimmune disease systemic lupus erythematosus (SLE). OGT is currently assessing partnership opportunities to commercialise these biomarker panels.
Clinical & Genomic Solutions: OGT’s Genefficiency™